表纸
市场调查报告书
商品编码
1009415

中国的Pantoprazole市场的相关调查报告书(2021年~2025年)

Investigation Report on China's Pantoprazole Market 2021-2025

出版日期: | 出版商: China Research and Intelligence | 英文 50 Pages | 商品交期: 最快1-2个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

中国市场中Pantoprazole的销售额,从2016年到2020年持续减少,销售额2020年为11亿6,200万人民币。另一方面,中国市场中Pantoprazole的销售额,从2016年到2020年整体有上升趋势,从2016年到2020年之间以3.06%的年复合成长率成长。

由于有效缓和COVID-19流行,Pantoprazole的销售额从2016年到2020年有复苏性的成长。成Pantoprazole,有稳定的治疗效果,良好的酸抑制效果,短期性的副作用较低这个优点。因此,中国的Pantoprazole的销售额,预计今后也维持成长趋势。

本报告提供中国的Pantoprazole市场的相关调查,市场规模和预测,价格,成长要素和机会等市场发展的影响因素分析,竞争情形,主要制造商/产品的简介等资讯。

目录

第1章 Pantoprazole的相关概念

  • Pantoprazole的适应症
  • 中国的Pantoprazole的开发
  • 中国的Pantoprazole的政府核准
  • COVID-19对中国的Pantoprazole销售的影响

第2章 中国的Pantoprazole销售(2016-2020)

  • Pantoprazole的销售量
    • 总销售额
    • 各地区的销售量
  • Pantoprazole的销售量
    • 整体销售量
    • 各地区销售量
  • 中国的各剂型Pantoprazole销售(2016-2020)
    • 注射
    • 肠可溶性涂料锭
    • 肠可溶性胶囊

第3章 2020年的中国的主要Pantoprazolemeka分析

  • 主要Pantoprazolemeka的市场占有率分析
    • 各销售额:市场占有率调查
    • 各销售量:市场占有率调查
  • Hangzhou Sino American Huadong Pharmaceutical Co., Ltd.
    • 企业简介
    • Panlisu (Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. 的Pantoprazole)在中国的销售
  • Nycomed GmbH
    • 企业简介
    • PANTOLOC (Nycomed GmbH的Pantoprazole)在中国的销售
  • Yangtze River Pharmaceutical Group Co Ltd.
    • 企业简介
    • Weidi (Yangtze River Pharmaceutical Group Co Ltd.的Pantoprazole)在中国的销售
  • Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.
    • 企业简介
    • Nuoke (Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.的Pantoprazole)在中国的销售
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd
    • 企业简介
    • Zhuodi (Chengdu Tiantaishan Pharmaceutical Co., Ltd. 的Pantoprazole)在中国的销售

第4章 中国的各种制造商Pantoprazole的价格(2020-2021)

  • Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. (Panlisu)
  • Nycomed GmbH (PANTOLOC)
  • Yangtze River Pharmaceutical Group Co Ltd. (Weidi)
  • Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. (Nuoke)
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd. (Zhuodi)

第5章 中国的Pantoprazole市场预测(2021-2025)

  • 中国的Pantoprazole市场开发的有影响力的要素
    • COVID-19对中国的Pantoprazole市场的影响
    • 市场成长要素和机会
    • 市场威胁与课题
  • 市场规模的预测
  • 市场趋势的预测
目录
Product Code: 2106515

Pantoprazole is the third proton pump inhibitor marketed globally. Compared with omeprazole, it has higher selectivity and bioavailability. Pantoprazole is more stable than omeprazole and lansola under weak acid conditions. The product of Pantoprazole, developed by Byk Gulden of Germany, can treat duodenal ulcer; gastric ulcer; moderate and severe reflux esophagitis. It was approved for listing in China in 1999. By the end of 2020, there are several manufacturers in the Chinese Pantoprazole market.

According to CRI's market research, the sales value of pantoprazole in the Chinese market has declined continuously from 2016 to 2020, and its sales value reached CNY 1.162 billion in 2020. The sales value of pantoprazole in the Chinese market has shown an overall upward trend from 2016 to 2020, with a CAGR of 3.06% from 2016 to 2020.

CRI expects that with the effective alleviation of the COVID-19 epidemic, the sales of pantoprazole will have a restorative growth from 2016 to 2020. Pantoprazole has the advantages of stable curative effect, good acid suppression effect, and small short-term side effects. Therefore, the sales of pantoprazole in China will maintain a growth trend in the future.

Topics Covered:

  • The impact of COVID-19 on China's Pantoprazole market
  • Sales value of China's Pantoprazole 2016-2020
  • Competitive landscape of China's Pantoprazole market
  • Prices of Pantoprazole in China
  • Prices of Pantoprazole in China by regions and manufacturers
  • Analysis of factors affecting the development of China's Pantoprazole market
  • Prospect of China's Pantoprazole market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Pantoprazole

  • 1.1 Indications for Pantoprazole
  • 1.2 Development of Pantoprazole in China
  • 1.3 Governmental Approval of Pantoprazole in China
  • 1.4 The Impact of COVID-19 on Pantoprazole sales in China

2 Sales of Pantoprazole in China, 2016-2020

  • 2.1 Sales Value of Pantoprazole
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Pantoprazole
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Pantoprazole by Dosage Form in China, 2016-2020
    • 2.3.1 Injection
    • 2.3.2 Enteric-coated Tablets
    • 2.3.3 Enteric-coated Capsules

3 Analysis of Major Pantoprazole Manufacturers in China in 2020

  • 3.1 Analysis of Market Share of Major Pantoprazole Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Hangzhou Sino American Huadong Pharmaceutical Co., Ltd.
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of Panlisu (Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. 's Pantoprazole) in China
  • 3.3 Nycomed GmbH
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of PANTOLOC (Nycomed GmbH's Pantoprazole) in China
  • 3.4 Yangtze River Pharmaceutical Group Co Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of Weidi (Yangtze River Pharmaceutical Group Co Ltd.'s Pantoprazole) in China
  • 3.5 Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.
    • 3.5.1 Enterprise Profile
    • 3.5.2 Sales of Nuoke (Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. 's Pantoprazole) in China
  • 3.6 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
    • 3.6.1 Enterprise Profile
    • 3.6.2 Sales of Zhuodi (Chengdu Tiantaishan Pharmaceutical Co., Ltd. 's Pantoprazole) in China

4 Prices of Pantoprazole for Different Manufacturers in China, 2020-2021

  • 4.1 Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. (Panlisu)
  • 4.2 Nycomed GmbH (PANTOLOC)
  • 4.3 Yangtze River Pharmaceutical Group Co Ltd. (Weidi)
  • 4.4 Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. (Nuoke)
  • 4.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. (Zhuodi)

5 Prospect of Chinese Pantoprazole Market, 2021-2025

  • 5.1 Influential Factors of Chinese Pantoprazole Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Pantoprazole Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Pantoprazole Injection Registration in China
  • Chart Patent Information About Pantoprazole Enteric-coated Tablets Registration in China
  • Chart Patent Information About Pantoprazole Enteric-coated Capsules Registration in China
  • Chart Sales Value of Pantoprazole Injection over the World
  • Chart Sales Value of Pantoprazole Enteric-coated Tablets over the World
  • Chart Sales Value of Pantoprazole Enteric-coated Capsules over the World
  • Chart Sales Value of Pantoprazole Injection in China, 2016-2020
  • Chart Sales Value of Pantoprazole Enteric-coated Tablets in China, 2016-2020
  • Chart Sales Value of Pantoprazole Enteric-coated Capsules in China, 2016-2020
  • Chart Sales Value of Pantoprazole Injection in China by Regions, 2016-2020
  • Chart Sales Value of Pantoprazole Enteric-coated Tablets in China by Regions, 2016-2020
  • Chart Sales Value of Pantoprazole Enteric-coated Capsules in China by Regions, 2016-2020
  • Chart Sales Volume of Pantoprazole Injection in China, 2016-2020
  • Chart Sales Volume of Pantoprazole Enteric-coated Tablets in China, 2016-2020
  • Chart Sales Volume of Pantoprazole Enteric-coated Capsules in China, 2016-2020
  • Chart Sales Volume of Pantoprazole Injection in China by Regions, 2016-2020
  • Chart Sales Volume of Pantoprazole Enteric-coated Tablets in China by Regions, 2016-2020
  • Chart Sales Volume of Pantoprazole Enteric-coated Capsules in China by Regions, 2016-2020
  • Chart Market Share by Sales Value of Top Pantoprazole Injection Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Pantoprazole Tablets Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Pantoprazole Enteric-coated Tablets Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Pantoprazole Enteric-coated Capsules Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of Panlisu in China, 2016-2020
  • Chart Sales Value and Volume of PANTOLOC in China, 2016-2020
  • Chart Sales Value and Volume of Weidi, 2016-2020
  • Chart Sales Value and Volume of Nuoke in China, 2016-2020
  • Chart Sales Value and Volume of Zhuodi in China, 2016-2020
  • Chart Referential Prices of Panlisu in China by Region, 2020-2021
  • Chart Referential Prices of PANTOLOC in China by Region, 2020-2021
  • Chart Referential Prices of Weidi, 2020-2021
  • Chart Referential Prices of Nuoke in China by Region, 2020-2021
  • Chart Referential Prices of Zhuodi in China by Region, 2020-2021
  • Chart Forecast on Sales Value of Pantoprazole Injection in China, 2021-2025
  • Chart Forecast on Sales Value of Pantoprazole Enteric-coated Tablets in China, 2021-2025
  • Chart Forecast on Sales Value of Pantoprazole Enteric-coated Capsules in China, 2021-2025
  • Chart Forecast on Sales Volume of Pantoprazole Injection in China, 2021-2025
  • Chart Forecast on Sales Volume of Pantoprazole Enteric-coated Tablets in China, 2021-2025
  • Chart Forecast on Sales Volume of Pantoprazole Enteric-coated Capsules in China, 2021-2025